News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Studies Show GlaxoSmithKline (GSK)'s HPV Vaccine Fights Cervical Cancer



11/9/2011 8:20:41 AM

Using GlaxoSmithKline's Cervarix vaccine to protect girls against the HPV virus that causes cervical cancer is so effective that health authorities could reduce the need for later cervical screening, scientists said on Wednesday. Researchers from Finland and the United States who published two studies in The Lancet Oncology journal found Cervarix "offers excellent protection" against two key strains of the human papillomavirus (HPV), particularly when given to young adolescent girls before they become sexually active.

Read at Fox News
Read at News Release
Read at Wall Street Journal
Read at US News


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES